FOMX Foamix Pharmaceuticals Ltd. - O

4.50
-0.15  -3%
Previous Close 4.65
Open 4.61
Price To book 1.49
Market Cap 167.50M
Shares 37,223,000
Volume 95,501
Short Ratio 11.21
Av. Daily Volume 299,234

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 data released December 2015
FDX104
Acne-like rash in cancer patients
Phase 2 top-line data released September 12, 2016. Endpoints met. Phase 3 trial to be initiation announced June 12, 2017 with top-line data due mid-2018.
FMX103
Papulopustular rosacea
Phase 3 data released March 27, 2017 - three of four primary endpoints met across two trials. Noted May 1, 2017 that third Phase 3 trial to be initiated mid-2017 with potential NDA filing 2H 2018.
FMX101
Acne
Update to be provided as it materializes.
FDX102
Impetigo

Latest News

  1. Foamix Pharmaceuticals to Present at the 2017 BIO International Convention
  2. Foamix Announces Dosing of First Patient in Phase 3 Rosacea Clinical Trials for FMX103 Minocycline Foam 1.5%
  3. Foamix Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference
  4. Edited Transcript of FOMX earnings conference call or presentation 10-May-17 12:30pm GMT
  5. Investor Network: Foamix Pharmaceuticals Ltd. to Host Earnings Call
  6. Foamix reports 1Q loss
  7. Foamix Reports First Quarter 2017 Financial Results and Provides Business Update
  8. Foamix Pharmaceuticals Announces Plans for Additional Phase 3 Trial for FMX101 in Moderate to Severe Acne
  9. Foamix Pharmaceuticals to Present at the 42nd Annual Deutsche Bank Health Care Conference
  10. Foamix Pharmaceuticals First Quarter Financial Results Conference Call & Webcast Scheduled for Tuesday, May 10
  11. Foamix Acne Drug Fails Late-Stage Study
  12. Foamix Reports Topline Results from Phase 3 Trials for FMX101 in Patients with Acne
  13. Xenon Pharma Dumps Acne Drug After Study Failure
  14. Foamix Pharmaceuticals Ltd. :FOMX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
  15. Foamix Pharmaceuticals Ltd. :FOMX-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017
  16. Foamix Pharmaceuticals to Present at the Barclays Capital Global Healthcare Conference
  17. Foamix Pharmaceuticals to Present at the ROTH Capital Partners 29th Annual Growth Conference
  18. Foamix Pharmaceuticals to Present at the Cowen & Company 37th Annual Healthcare Conference
  19. Foamix Pharmaceuticals to Participate in a Panel Discussion at the Dermatology Innovation Forum
  20. Edited Transcript of FOMX earnings conference call or presentation 22-Feb-17 1:30pm GMT